Key facts: ImmunityBio bladder trial meets endpoint; Q3 sales rise 53%
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original sources.
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original sources.